Initially focusing on Fragile X Syndrome clinical trials of mGlur5 antagonists and related pharmaceuticals.
While at dinner with some friends who are doctors and other healthcare workers, a discussion of comments made by President Obama in his 2016 State of the Union with respect to cancer research came up. My friends and colleagues were excited by the possibility of diminishing data “siloing”. This is what the President had to […]
The following video is shared from the FRAXA Research Foundation, whose research director, Dr. Michael Tranfaglia, M.D., gave a talk at the April 21, 2015 Stanford University Intellectual and Developmental Disability Center (IDD-C) research symposium. Dr. Tranfaglia provided both a review of the bases for recent clinical trials as well as various avenues for future […]
Publications as an alternative or supplement to CTgov? ClinicalTrials.gov (CTgov) states that links are automatically provided in the Results tab for any publication [in PubMed] that contains the NCT identifier for the trial. Unfortunately, we can see from the survey of Fragile X Syndrome (FXS) trials on CTgov on the prior page, that no clinical […]